Beyond the Pandemic: How the mRNA Vaccine and Therapeutics Market is Shaping Modern Medicine
For decades, modern drug development moved at a measured, cautious pace. Researchers spent years identifying targets, optimizing delivery mechanisms, and scaling manufacturing for complex biologic drugs. Then came a quiet scientific revolution built on a fragile, elusive strand of genetic code. Suddenly, scientists realized that messenger RNA was not merely a messenger; it was a programmable instruction manual capable of turning human cells into temporary medicine factories.

This versatility has fundamentally transformed pharmaceutical pipelines across the globe. According to a comprehensive industry evaluation by Roots Analysis, the global mRNA vaccine and therapeutics market, valued at USD 9 million in 2026, is projected to reach USD 17,036 million by 2035, representing a high CAGR during the forecast period 2026 to 2035. This explosive expansion reflects a paradigm shift away from traditional small-molecule drugs and protein-based biologics toward precision genetic medicine.
read More: https://www.rootsanalysis.com/....reports/mrna-therape